411 related articles for article (PubMed ID: 10993883)
1. Requirement for ERK activation in cisplatin-induced apoptosis.
Wang X; Martindale JL; Holbrook NJ
J Biol Chem; 2000 Dec; 275(50):39435-43. PubMed ID: 10993883
[TBL] [Abstract][Full Text] [Related]
2. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
Okano J ; Rustgi AK
J Biol Chem; 2001 Jun; 276(22):19555-64. PubMed ID: 11278851
[TBL] [Abstract][Full Text] [Related]
4. The MEK1 inhibitor PD98059 sensitizes C8161 melanoma cells to cisplatin-induced apoptosis.
Mandic A; Viktorsson K; Heiden T; Hansson J; Shoshan MC
Melanoma Res; 2001 Feb; 11(1):11-9. PubMed ID: 11254111
[TBL] [Abstract][Full Text] [Related]
5. Sodium orthovanadate potentiates EGCG-induced apoptosis that is dependent on the ERK pathway.
Choi YJ; Lim SY; Woo JH; Kim YH; Kwon YK; Suh SI; Lee SH; Choi WY; Kim JG; Lee IS; Park JW; Kwon TK
Biochem Biophys Res Commun; 2003 May; 305(1):176-85. PubMed ID: 12732214
[TBL] [Abstract][Full Text] [Related]
6. The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway.
Sanna B; Debidda M; Pintus G; Tadolini B; Posadino AM; Bennardini F; Sava G; Ventura C
Arch Biochem Biophys; 2002 Jul; 403(2):209-18. PubMed ID: 12139970
[TBL] [Abstract][Full Text] [Related]
7. Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes.
Scheller C; Sopper S; Ehrhardt C; Flory E; Chen P; Koutsilieri E; Ludwig S; ter Meulen V; Jassoy C
Eur J Immunol; 2002 Sep; 32(9):2471-80. PubMed ID: 12207331
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK.
Allan LA; Morrice N; Brady S; Magee G; Pathak S; Clarke PR
Nat Cell Biol; 2003 Jul; 5(7):647-54. PubMed ID: 12792650
[TBL] [Abstract][Full Text] [Related]
9. Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines.
Woessmann W; Chen X; Borkhardt A
Cancer Chemother Pharmacol; 2002 Nov; 50(5):397-404. PubMed ID: 12439598
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
Fukazawa H; Noguchi K; Murakami Y; Uehara Y
Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
[TBL] [Abstract][Full Text] [Related]
12. Role of caspases in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils.
Zhang JP; Wong CK; Lam CW
Clin Exp Immunol; 2000 Oct; 122(1):20-7. PubMed ID: 11012613
[TBL] [Abstract][Full Text] [Related]
13. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors.
Tran SE; Holmstrom TH; Ahonen M; Kahari VM; Eriksson JE
J Biol Chem; 2001 May; 276(19):16484-90. PubMed ID: 11278665
[TBL] [Abstract][Full Text] [Related]
14. Activation of stress-activated protein kinase/c-Jun NH2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3-like proteases but is dispensable for cell death.
Ozaki I; Tani E; Ikemoto H; Kitagawa H; Fujikawa H
J Biol Chem; 1999 Feb; 274(9):5310-7. PubMed ID: 10026138
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-phosphate activates Erk-1/-2 by transactivating epidermal growth factor receptor in rat-2 cells.
Kim JH; Kim JH; Song WK; Kim JH; Chun JS
IUBMB Life; 2000 Aug; 50(2):119-24. PubMed ID: 11185956
[TBL] [Abstract][Full Text] [Related]
16. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.
Iijima Y; Laser M; Shiraishi H; Willey CD; Sundaravadivel B; Xu L; McDermott PJ; Kuppuswamy D
J Biol Chem; 2002 Jun; 277(25):23065-75. PubMed ID: 11940578
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
18. Activation of extracellular signal-regulated kinases potentiates hemin toxicity in astrocyte cultures.
Regan RF; Wang Y; Ma X; Chong A; Guo Y
J Neurochem; 2001 Nov; 79(3):545-55. PubMed ID: 11701758
[TBL] [Abstract][Full Text] [Related]
19. MEK1/2 inhibitors promote Ara-C-induced apoptosis but not loss of Deltapsi(m) in HL-60 cells.
Yu C; Wang Z; Dent P; Grant S
Biochem Biophys Res Commun; 2001 Sep; 286(5):1011-8. PubMed ID: 11527401
[TBL] [Abstract][Full Text] [Related]
20. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis.
Andreka P; Zang J; Dougherty C; Slepak TI; Webster KA; Bishopric NH
Circ Res; 2001 Feb; 88(3):305-12. PubMed ID: 11179198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
